Our Services
Medical Information
Helpful Resources
Published on: 9/24/2026
Stopping Zoloft (sertraline) suddenly is generally not recommended, because abruptly ending it can trigger antidepressant discontinuation syndrome, with symptoms like dizziness, nausea, flu-like aches, irritability, insomnia, vivid dreams, and "brain zaps." These effects usually begin within two to four days and can last one to three weeks, and stopping early also raises the risk that depression or anxiety symptoms will return. Doctors typically taper the dose gradually over several weeks or months, with the timeline depending on your dose, how long you have taken it, and how your body responds. Several important factors affect how risky a sudden stop may be, including pregnancy, other medications, and any worsening mood or suicidal thoughts, so see below to understand more before making changes.
Because withdrawal symptoms and returning depression or anxiety can feel very similar but need very different responses, it helps to sort out what you are actually experiencing: take a free, instant, online symptom check to better understand your symptoms and plan your next steps with a clinician.
Last reviewed for medical accuracy: 09/24/2026
Is It Safe to Stop Zoloft Suddenly?
Zoloft (sertraline) is a widely prescribed SSRI (selective serotonin reuptake inhibitor) used to treat major depressive disorder, anxiety disorders, and other mood conditions. When managed correctly, Zoloft for depression can restore balance in brain chemistry, improve mood, and help you feel more like yourself. However, deciding to stop Zoloft—especially without medical guidance—can lead to unpleasant and potentially serious effects.
Why You Shouldn’t Stop Zoloft Abruptly
SSRIs like Zoloft work by slowly adjusting the levels of serotonin in your brain. When you stop taking them suddenly, your system doesn’t have time to adapt, and this can trigger a cluster of symptoms called SSRI discontinuation syndrome. Common features include:
• Flu-like symptoms: chills, headache, fatigue
• Gastrointestinal upset: nausea, diarrhea
• Sleep disturbances: vivid dreams, insomnia
• Sensory changes: “brain zaps,” tingling sensations
• Mood swings: irritability, anxiety, low mood
While these signs are often temporary, they can range from mildly uncomfortable to severely disruptive. In rare cases, sudden discontinuation could unmask underlying depression or anxiety, increasing the risk of relapse or self-harm.
How Abrupt Stopping Affects Your Brain
Real-World Impact
• Up to 80% of patients report at least one discontinuation symptom if they stop SSRIs suddenly.
• Some symptoms, like “brain zaps,” can persist for weeks—impacting work, relationships, and daily life.
• In severe cases, people have been hospitalized for dehydration (from severe vomiting/diarrhea) or dangerous mood swings.
Safe Strategies to Stop Zoloft
Consult Your Prescriber
Follow a Gradual Taper Schedule
Keep a Symptom Diary
Consider Switching to a Longer-Acting SSRI (If Advised)
Integrate Supportive Therapies
Monitoring Yourself at Home
If you’re planning to stop Zoloft, consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker to help you understand any new or worsening signs. This tool can guide you on which symptoms warrant prompt medical attention.
Key Warning Signs to Watch For
• Persistent worsening of mood or anxiety after dose reductions
• Suicidal thoughts or behaviors
• Severe physical symptoms: chest pain, shortness of breath, uncontrollable vomiting or diarrhea
• Confusion, hallucinations, extreme agitation
If any of these occur, stop tapering and speak to your doctor immediately—or go to the nearest emergency department if the situation is life-threatening.
Common Myths and Facts
Myth: “If I feel fine after a week off Zoloft, I’m cured.”
Fact: Discontinuation symptoms can show up weeks after stopping. Mood disorders can relapse if you exit treatment too quickly.
Myth: “Tapering is only for long-term users.”
Fact: Even people on Zoloft for 6–8 weeks may experience withdrawal. Always taper under supervision.
Myth: “Natural remedies can replace a taper.”
Fact: Supplements and herbs might help mood, but they don’t replace a medically guided taper. Some herbs can even interact badly with SSRIs.
Planning Your Taper: A Sample Outline
Note: This is a hypothetical example. Never follow a taper plan without consulting your prescriber.
| Week | Zoloft Dose |
|---|---|
| 1–2 | 100 mg → 75 mg |
| 3–4 | 75 mg → 50 mg |
| 5–6 | 50 mg → 25 mg |
| 7–8 | 25 mg → 12.5 mg |
| 9–10 | 12.5 mg → 0 mg |
If any step triggers significant symptoms, your doctor may extend it to 4–6 weeks or more.
When to Reach Out for Help
• You experience new or worsening suicidal thoughts.
• Discontinuation symptoms severely impair your daily functioning.
• Physical symptoms (e.g., dehydration, severe dizziness) become alarming.
• You simply feel you cannot cope with the taper on your own.
Always remember: the goal is to minimize discomfort and protect your mental health. No one should have to endure severe withdrawal alone.
Final Thoughts
Stopping Zoloft suddenly is not recommended. A carefully planned taper, guided by your doctor, gives your brain time to readjust and reduces the risk of discontinuation syndrome. If you’re considering coming off Zoloft for depression:
Above all, never hesitate to speak to a doctor if you’re unsure or if you experience troubling symptoms. Your safety and well-being are the highest priority.
(References)
* Fava GA, Gatti A, Belaise C, Guidi J, Offidani E. Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review. Psychother Psychosom. 2015;84(2):72-81. doi: 10.1159/000370338. Epub 2015 Feb 21. PMID: 25721705.
* Gatto EM, Aldinio V, Parisi V, Persi G, Da Prat G, Bullrich MB, Sanchez P, Rojas G. Sertraline-induced Hemichorea. Tremor Other Hyperkinet Mov (N Y). 2017;7:518. doi: 10.7916/D8XK999F. Epub 2017 Dec 18. PMID: 29276648; PMCID: PMC5740228.
* Garrett AR, Hawley JS. SSRI-associated bruxism: A systematic review of published case reports. Neurol Clin Pract. 2018 Apr;8(2):135-141. doi: 10.1212/CPJ.0000000000000433. PMID: 29708207; PMCID: PMC5914744.
* Chen A, Copeli F, Metzger E, Cloutier A, Osser DN. The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An update on management of behavioral and psychological symptoms in dementia. Psychiatry Res. 2021 Jan;295:113641. doi: 10.1016/j.psychres.2020.113641. Epub 2020 Dec 13. PMID: 33340800.
* Lewis G, Marston L, Duffy L, Freemantle N, Gilbody S, Hunter R, Kendrick T, Kessler D, Mangin D, King M, Lanham P, Moore M, Nazareth I, Wiles N, Bacon F, Bird M, Brabyn S, Burns A, Clarke CS, Hunt A, Pervin J, Lewis G. Maintenance or Discontinuation of Antidepressants in Primary Care. N Engl J Med. 2021 Sep 30;385(14):1257-1267. doi: 10.1056/NEJMoa2106356. PMID: 34587384.
* Kishi T, Ikuta T, Sakuma K, Okuya M, Hatano M, Matsuda Y, Iwata N. Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis. Mol Psychiatry. 2023 Jan;28(1):402-409. doi: 10.1038/s41380-022-01824-z. Epub 2022 Oct 17. PMID: 36253442; PMCID: PMC9812779.
* McGee D, Hanley C, Reynolds A, Smyth S. Clarithromycin-Induced Visual Hallucinations. Neuroophthalmology. 2022;46(5):319-321. doi: 10.1080/01658107.2022.2041046. Epub 2022 Mar 2. PMID: 36337228; PMCID: PMC9635542.
* Strawn JR, Mills JA, Poweleit EA, Ramsey LB, Croarkin PE. Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents. Pharmacotherapy. 2023 Jul;43(7):675-690. doi: 10.1002/phar.2767. Epub 2023 Jan 27. PMID: 36651686; PMCID: PMC10378577.
* Davis LL, Behl S, Lee D, Zeng H, Skubiak T, Weaver S, Hefting N, Larsen KG, Hobart M. Brexpiprazole and Sertraline Combination Treatment in Posttraumatic Stress Disorder: A Phase 3 Randomized Clinical Trial. JAMA Psychiatry. 2025 Mar 1;82(3):218-227. doi: 10.1001/jamapsychiatry.2024.3996. PMID: 39693081; PMCID: PMC11883513.
* Rissardo JP, Fornari Caprara AL, Bhal N, Repudi R, Zlatin L, Walker IM. Drug-Induced Myoclonus: A Systematic Review. Medicina (Kaunas). 2025 Jan 15;61(1). doi: 10.3390/medicina61010131. Epub 2025 Jan 15. PMID: 39859113; PMCID: PMC11767161.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.